Prosthesis-Patient Mismatch after Transcatheter Aortic Valve Implantation Using the Edwards SAPIEN Prosthesis

被引:17
|
作者
Van Linden, Arnaud [1 ,2 ]
Kempfert, Joerg [1 ,2 ]
Blumenstein, Johannes [2 ]
Rastan, Ardawan [1 ]
Holzhey, David [1 ]
Lehmann, Sven [1 ]
Mohr, Friedrich W. [1 ]
Walther, Thomas [2 ]
机构
[1] Univ Leipzig, Heartctr, Dept Cardiac Surg, D-04109 Leipzig, Germany
[2] Kerckhoff Klin Bad Nauheim, Dept Cardiac Surg, Bad Nauheim, Germany
来源
THORACIC AND CARDIOVASCULAR SURGEON | 2013年 / 61卷 / 05期
关键词
aortic valve and root; echocardiography; outcomes; SHORT-TERM; CLINICAL IMPACT; REPLACEMENT; MORTALITY; POSITION; STENOSIS;
D O I
10.1055/s-0032-1311534
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Prosthesis-patient mismatch (PPM) is defined as a too small effective orifice area (EOA) of the prosthetic valve in relation to the patient's body size and has been documented to be related to adverse outcomes after conventional aortic valve replacement (AVR). Aim of this study was to analyze the incidence of PPM after transcatheter aortic valve implantation (T-AVI) using the Edwards SAPIEN prosthesis and its relation to postoperative outcome. Methods 200 consecutive high-risk patients underwent transapical aortic valve implantation (TA-AVI) between February 2006 and January 2009 and fulfilled 1 year follow-up were included. Severe PPM was defined as indexed EOA (EOAi) <0.65 cm(2)/m(2) and moderate PPM as EOAi = 0.65-0.85 cm(2)/m(2), EOA was calculated from transthoracic echocardiographic (TTE) measurements using the continuity equation. Total 112 patients with sufficient postoperative TTE image quality formed the study group. Results EOAi increased from 0.3 +/- 0.1 cm(2)/m(2) (preoperatively) to 1.1 +/- 0.4 cm(2)/m(2) after TA-AVI (p < 0.001). According to the standard definitions, PPM was seen in 38.4% of the patients and 9.8% presented with severe PPM. The occurrence of PPM had neither an effect on clinical outcome in terms of NYHA class nor on survival. Patients with PPM had significantly higher postoperative transprosthetic gradients (mean gradient 10.4 +/- 4.1 versus 7.1 +/- 3.0 mm Hg, p < 0.001). Based on the in vitro EOA data obtained from pulse duplicator measurements, however, none of the patients was judged to have PPM. Conclusion Transcatheter AVI provides good antegrade hemodynamic function and EOAi improves significantly. According to standardized evaluations PPM occurs after TA-AVI, but it is not associated with adverse outcomes. Thus use of the continuity equation may not adequately reflect the situation after T-AVI or the current definition of PPM is not suitable for T-AVI prostheses.
引用
收藏
页码:414 / 420
页数:7
相关论文
共 50 条
  • [1] Prosthesis-patient mismatch after transcatheter aortic valve implantation
    Leone, Pier Pasquale
    Pagnesi, Matteo
    Regazzoli, Damiano
    Latib, Azeem
    [J]. GIORNALE ITALIANO DI CARDIOLOGIA, 2020, 21 (11) : 26S - 34S
  • [2] Prosthesis-patient mismatch after transcatheter aortic valve implantation
    Miyasaka, Masaki
    [J]. CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2022, 37 (04) : 615 - 625
  • [3] Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Implantation
    Takagi, Hisato
    Umemoto, Takuya
    [J]. ANNALS OF THORACIC SURGERY, 2016, 101 (03): : 872 - 880
  • [4] PROSTHESIS-PATIENT MISMATCH FOLLOWING EDWARDS SAPIEN 3 TRANSCATHETER AORTIC VALVE REPLACEMENT
    Marah, Naddi
    Agha, Ali
    Monlezun, Dominique J.
    Smalling, Richard
    Balan, Prakash
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1176 - 1176
  • [5] Determinants of Prosthesis-Patient Mismatch in Patients Undergoing Edwards Sapien and Sapien 3 Transcatheter Aortic Valve Replacement
    Vallabhaneni, Srilakshmi
    Matka, Marsel
    Thacker, Purujit
    Meera, Srinidhi
    Carey, Matthew
    Sarnoski, Christopher
    Durkin, Raymond
    Durkin, Michael
    Olenchock, Stephen
    Amortegui, Jose
    Fitzpatrick, Raymond J.
    Shirani, Jamshid
    [J]. CIRCULATION, 2019, 140
  • [6] Incidence and Impact of Prosthesis-Patient Mismatch after Transcatheter Aortic Valve Implantation
    Bleiziffer, Sabine
    Hettich, Ina
    Hutter, Andrea
    Wagner, Anke
    Deutsch, Marcus-Andre
    Piazza, Nicolo
    Lange, Ruediger
    [J]. JOURNAL OF HEART VALVE DISEASE, 2013, 22 (03): : 309 - 316
  • [7] Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement
    Herrmann, Howard C.
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (21) : 2183 - 2185
  • [8] Incidence and clinical outcome of prosthesis-patient mismatch after transcatheter aortic valve implantation with the CoreValve prosthesis
    Munoz-Garcia, Antonio J.
    Munoz-Garcia, Manuel
    Carrasco-Chinchilla, Fernando
    Molina-Mora, Maria J.
    Rodriguez-Bailon, Isabel
    Dominguez-Franco, Antonio J.
    Jimenez-Navarro, Manuel F.
    Alonso-Briales, Juan H.
    Gomez-Doblas, Juan J.
    Hernandez-Garcia, Jose M.
    de Teresa-Galvan, Eduardo
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (03) : 1074 - 1076
  • [9] Clinical and Technical Challenges of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Implantation
    Leone, Pier Pasquale
    Fazzari, Fabio
    Cannata, Francesco
    Sanz-Sanchez, Jorge
    Mangieri, Antonio
    Monti, Lorenzo
    Cozzi, Ottavia
    Stefanini, Giulio Giuseppe
    Bragato, Renato
    Colombo, Antonio
    Reimers, Bernhard
    Regazzoli, Damiano
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [10] Hemodynamic and Clinical Impact of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Implantation
    Ewe, See Hooi
    Muratori, Manuela
    Delgado, Victoria
    Pepi, Mauro
    Tamborini, Gloria
    Fusini, Laura
    Klautz, Robert J. M.
    Gripari, Paola
    Bax, Jeroen J.
    Fusari, Melissa
    Schalij, Martin J.
    Marsan, Nina Ajmone
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (18) : 1910 - 1918